CARDIOVASCULAR DISEASES AS A COMPLICATION LEADING TO CHRONIC KIDNEY DISEASE: CLINICAL SIGNS, EARLY DIAGNOSIS, AND PREVENTION

ASL MANBA
Ushbu maqola dastlab SYNAPSES: INSIGHTS ACROSS THE DISCIPLINES jurnalida nashr etilgan.

ogli, Doliyev Ahmadjon Ulugbek, Erkinjonovna, Sadullayeva Laziza (2026) CARDIOVASCULAR DISEASES AS A COMPLICATION LEADING TO CHRONIC KIDNEY DISEASE: CLINICAL SIGNS, EARLY DIAGNOSIS, AND PREVENTION. SYNAPSES: INSIGHTS ACROSS THE DISCIPLINES.

To'liq matn arxivda mavjud emas — maqolaning asl manbasiga havola pastda berilgan.

Annotatsiya

Cardiovascular diseases, particularly chronic heart failure, play a significant role in the development of chronic kidney disease (CKD) and constitute type 2 cardiorenal syndrome. According to Global Burden of Disease study data, chronic kidney disease ranks as the 9th leading cause of death worldwide, associated with 1.48 million deaths annually, and occupies the 12th position in terms of years lived with disability. In patients with CKD, the rate of cardiovascular complications and mortality can reach 40–50%. This article provides an in-depth analysis of the clinical manifestations of chronic kidney disease developing as a complication of cardiovascular diseases, the pathophysiological mechanisms of cardiorenal syndrome, its association with diabetes mellitus, methods of early diagnosis, and modern preventive measures.

Hujjat turi: Maqola
Mualliflar:
Muallif
Email
ogli, Doliyev Ahmadjon Ulugbek
UNSPECIFIED
Erkinjonovna, Sadullayeva Laziza
UNSPECIFIED
Jurnal / Nashr: SYNAPSES: INSIGHTS ACROSS THE DISCIPLINES
Nashriyot: Research Science and Innovation House
Sana: 4 May 2026
DOI / ID: oai:ojs.pkp.sfu.ca:article/18310
Kalit so'zlar: type 2 cardiorenal syndrome, glomerular filtration rate, urinary albumin-to-creatinine ratio, sodium-glucose cotransporter 2 inhibitors, Dapagliflozin in Patients with Chronic Kidney Disease study, Empagliflozin in Patients with Chronic Kidney Disease study, finerenone, biomarkers, early screening, prevention
Mavzular: ?? type 2 cardiorenal syndrome, glomerular filtration rate, urinary albumin-to-creatinine ratio, sodium-glucose cotransporter 2 inhibitors, Dapagliflozin in Patients with Chronic Kidney Disease study, Empagliflozin in Patients with Chronic Kidney Disease stu ??
Eslatma: Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/18310)
URI: https://arxiv.universalpublishings.com/id/eprint/87751
Amallar
[pin missing: title]
[pin missing: title]